about
Cancer Salivary Biomarkers for Tumours Distant to the Oral CavityAntileukemia Effect of Ciclopirox Olamine Is Mediated by Downregulation of Intracellular Ferritin and Inhibition β-Catenin-c-Myc Signaling Pathway in Glucocorticoid Resistant T-ALL Cell LinesThe Promise of Pharmacogenomics in Reducing Toxicity During Acute Lymphoblastic Leukemia Maintenance Treatment.TropicALL study: Thromboprophylaxis in Children treated for Acute Lymphoblastic Leukemia with Low-molecular-weight heparin: a multicenter randomized controlled trialIdentification of potential predictive markers of dexamethasone resistance in childhood acute lymphoblastic leukemiaLow dose of 2-deoxy-D-glucose kills acute lymphoblastic leukemia cells and reverses glucocorticoid resistance via N-linked glycosylation inhibition under normoxia.Effects of the application of therapeutic massage in children with cancer: a systematic review.The contributions of the European Medicines Agency and its pediatric committee to the fight against childhood leukemiaButein inhibits cell proliferation and induces cell cycle arrest in acute lymphoblastic leukemia via FOXO3a/p27kip1 pathwayL-Asparaginase Isolated from Phaseolus vulgaris Seeds Exhibited Potent Anti-Acute Lymphoblastic Leukemia Effects In-Vitro and Low Immunogenic Properties In-Vivo.Pharmacogenomics in pediatric acute lymphoblastic leukemia: promises and limitations.Differential expression pattern of protein markers for predicting chemosensitivity of dexamethasone-based chemotherapy of B cell acute lymphoblastic leukemia.Genomic and transcriptomic profiling of resistant CEM/ADR-5000 and sensitive CCRF-CEM leukaemia cells for unravelling the full complexity of multi-factorial multidrug resistanceHypertriglyceridemia during asparaginase treatment in children with acute lymphoblastic leukemia correlates with antithrombin activity in adolescents.Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia in Adults.Scientific Achievements May Not Reach Everyone: Understanding Disparities in Acute Leukemia.The combination of bortezomib with chemotherapy to treat relapsed/refractory acute lymphoblastic leukaemia of childhood.Treatment of Young Adults with Acute Lymphoblastic Leukemia.Continuing challenges and current issues in acute lymphoblastic leukemia.Inferior outcomes for black children with high risk acute lymphoblastic leukemia and the impact of socioeconomic variables.Role of peripheral blood minimum residual disease at day 8 of induction therapy in high-risk pediatric patients with acute lymphocytic leukemiaInvasive fungal infection (IFI) in pediatric leukemia: better outcome with ACT.Voriconazole plus caspofungin for treatment of invasive fungal infection in children with acute leukemia.CARs on a highway with roadblocks.Genome-Wide Study Links PNPLA3 Variant With Elevated Hepatic Transaminase After Acute Lymphoblastic Leukemia Therapy.Changes in cognition and dendritic complexity following intrathecal methotrexate and cytarabine treatment in a juvenile murine model.Treatment of vincristine-induced ileus with metoclopramide: A case report.A retrospective comparison of Escherichia coli and polyethylene glycol-conjugated asparaginase for the treatment of adolescents and adults with newly diagnosed acute lymphoblastic leukemia.Effects of 1,3,5-triphenyl-4,5-dihydro-1H-pyrazole derivatives on cell-cycle and apoptosis in human acute leukemia cell lines.CD47-ligation induced cell death in T-acute lymphoblastic leukemia.Therapeutic vaccination with 4-1BB co-stimulation eradicates mouse acute myeloid leukemiaThe effect of intravenous hydration strategy on plasma methotrexate clearance during intravenous high-dose methotrexate administration in pediatric oncology patientsBone relapse in T-lineage acute lymphoblastic leukemia in a childThe potential of CAR T therapy for relapsed or refractory pediatric and young adult B-cell ALLHigh-dose methotrexate vs. Capizzi methotrexate for the treatment of childhood T-cell acute lymphoblastic leukemiaHistidine catabolism is a major determinant of methotrexate sensitivity
P2860
Q28066265-C87656FF-73AB-469E-AE4B-77DBB8141F26Q28553697-58310B27-27B1-4357-9A8F-544672D5B91FQ33632120-6695B83E-C45A-4B0C-8081-DDF86778DAAAQ33655100-9F5DCD5B-CD5B-4799-99B7-6501ADF9B4DDQ33714739-6480D317-AFDB-469F-8A3C-A32C6F08EE12Q33761600-0718F334-1E9F-4454-B16D-6AC76FAEE7ACQ33857782-A94F07CC-9A21-45F8-AFE3-59B54BDD59B2Q36267151-C6E32E77-DDC6-442F-8C4C-4F3C23934219Q37109845-D96CAFA8-5D4A-43F2-ABBE-75B7719949DBQ37379199-347AF965-FE01-4B42-B5E7-813D6A756DFFQ38688039-ED990171-BB05-45D3-9B27-F0FD42EBB111Q38701181-23E62CBD-FB01-4890-B92D-004A746538BFQ38797514-1DEC1828-DB88-4598-A095-C9B312440133Q38821455-756FC15A-7080-4454-8BB2-10D93CEFE622Q38840423-F6FDFE41-9AFB-4C4C-8F7D-16AD953DAD83Q38840936-F2EBF8AD-9214-492C-8BD4-F28D64525C99Q39002810-D85C24BC-7DCC-49C6-887A-CF1EAA178E93Q39206217-40DB02C3-C666-432E-9ED5-9E986D1FFBF3Q39366299-683522A0-5E49-4379-9B3D-C89EB7391AEEQ39369458-FB7AF67F-A972-484E-9052-08618052A9E6Q41981064-3B434470-38E4-47C8-8A1C-94D1FB7FBE35Q42377766-7859CC40-1E96-4F04-85AC-E5EDD7576D71Q42377772-BE59BEA7-2DD9-438F-8A17-BE6053DF9EF3Q45875485-86AD5D66-DAA9-46FE-85B4-D3B2A6ACA238Q46844249-29D60B2B-30BE-4CB7-AF84-61BF4114714FQ47327834-C58C9980-2B70-4D30-AA0A-FC86F269FA81Q48147607-A12B0BE1-1F31-4C2D-B0D1-5034E4BCA8A0Q49412789-B1220091-B3A5-4835-AB17-C4CAF401B080Q52793168-F68F55DD-F481-4119-84B2-BE3314541442Q55025781-125FE170-8032-40AA-9A56-F5E34DCAFC78Q57138588-0AD6158F-1FB3-4D7F-A653-4C12FA949428Q57816122-744C24E7-8472-4367-BE9E-D9FC6C2312BFQ58701685-F5502B88-7271-4832-8F8B-18974B546CAFQ58767159-722DCB7F-5FE9-41BC-8504-7B499D592F51Q58776389-D01335B6-1F10-4AD3-B8F0-EED841A65E3CQ59071518-F83D366A-11EC-465C-A97E-6E5502C6FA07
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Treatment of pediatric acute lymphoblastic leukemia.
@ast
Treatment of pediatric acute lymphoblastic leukemia.
@en
type
label
Treatment of pediatric acute lymphoblastic leukemia.
@ast
Treatment of pediatric acute lymphoblastic leukemia.
@en
prefLabel
Treatment of pediatric acute lymphoblastic leukemia.
@ast
Treatment of pediatric acute lymphoblastic leukemia.
@en
P2860
P1476
Treatment of pediatric acute lymphoblastic leukemia.
@en
P2093
Patrick A Brown
Stacy L Cooper
P2860
P356
10.1016/J.PCL.2014.09.006
P577
2014-10-18T00:00:00Z